After a difficult 18 months for the Australian biotechnology sector, Melbourne-based drug developer Acrux has boosted the industry’s confide…
After a difficult 18 months for the Australian biotechnology sector, Melbourne-based drug developer Acrux has boosted the industry’s confide…
Australian biotech company Acrux has announced plans to export its new testosterone treatment across the globe, following a trial which show…
